Physician profile
Justin B Hare
NPI 1265790182
$6,896.44
in general payments reported to CMS, 2019-2025
31 companies · $726 in 2025
The $726 reported for 2025 was more than what 84% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $273 · 2021: $296 · 2022: $403 · 2023: $3,348 · 2024: $1,567 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,050 · Food and Beverage: $2,592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,050.39 |
| Food and Beverage | $2,591.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,301.10 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Vanta Adaptivestim |
| Boston Scientific Corporation | $1,345.28 | 2022-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $1,166.48 | 2022-2025 | Nalu Neurostimulation System |
| Abbott Laboratories | $683.11 | 2019-2025 | Eterna, Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $309.94 | 2022-2025 | Relistor |
| Forte Bio-Pharma LLC | $124.30 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Mml US, INC. | $81.54 | 2023 | Reactiv8 |
| Si-Bone, INC. | $76.16 | 2019-2025 | |
| Saluda Medical Americas, INC. | $68.42 | 2023-2025 | Evoke, Evoke Scs |
| Foundation Fusion Solutions, LLC | $67.89 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $66.31 | 2025 | |
| Collegium Pharmaceutical, INC. | $59.40 | 2023-2025 | Xtampza |
| Pfizer INC. | $54.44 | 2019-2021 | |
| Horizon Therapeutics Plc | $52.40 | 2019-2021 | |
| Stryker Corporation | $51.60 | 2025 | Mild Device Kit |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $43.68 | 2019 | |
| Depuy Synthes Sales INC. | $38.83 | 2019 | |
| Daiichi Sankyo INC. | $30.70 | 2019 | |
| Valinor Pharma, LLC | $30.37 | 2025 | Movantik |
| Averitas Pharma INC. | $28.58 | 2025 | Qutenza |
| Ultragenyx Pharmaceutical INC. | $27.72 | 2023 | |
| Painteq LLC | $26.45 | 2023 | Painteq |
| Merit Medical Systems INC | $23.76 | 2021 | |
| Relievant Medsystems, INC. | $19.64 | 2023 | Intracept |
| Abbvie INC. | $18.87 | 2022 | |
| Siemens Medical Solutions USA, INC. | $17.78 | 2022 | |
| Alexion Pharmaceuticals, INC. | $17.38 | 2019 | |
| Spr Therapeutics, INC | $17.18 | 2023 | Sprint Pns System |
| Protega Pharmaceutials INC | $16.21 | 2022 | |
| Azurity Pharmaceuticals, INC. | $15.92 | 2023 | Horizant |
| Pacira Pharmaceuticals Incorporated | $15.00 | 2025 | Iovera, Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Hare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.